LAURA POPECK: Open Payments
NPI 1871227587 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 32 payments from 18 companies in 2025. Trend: 2023 $681 · 2024 $870 · 2025 $861
Food & beverage: $776Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $196 |
| SOBI, INC | 2 | $108 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Incyte Corporation | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| GENZYME CORPORATION | 1 | $50 |
| TAIHO ONCOLOGY, INC. | 2 | $39 |
| ABBVIE INC. | 1 | $30 |
Products named: KEYTRUDA, WAYRILZ, KISQALI, ENHERTU, SCEMBLIX, LONSURF, OPDIVO, OJJAARA.
Industry payments across LA — which companies pay providers there.
